Tsubota Laboratory Incorporated (TYO:4890)
Japan · Delayed Price · Currency is JPY 277.00
-4.00 (-1.42%)
Aug 21, 2026, 3:30 PM JST
Tsubota Laboratory Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 699.26 | 969 | 1,538 | 1,883 | 2,161 | 1,174 |
Cash & Short-Term Investments | 699.26 | 969 | 1,538 | 1,883 | 2,161 | 1,174 |
Cash Growth | -52.53% | -37.00% | -18.32% | -12.86% | 84.07% | 92.46% |
Accounts Receivable | 190.62 | 14 | 545 | 17 | 17 | 4 |
Other Receivables | 109.83 | 83 | 62 | 28 | 9 | - |
Receivables | 300.45 | 97 | 607 | 45 | 26 | 4 |
Inventory | 188.04 | 188 | 285 | 285 | 355 | 308 |
Prepaid Expenses | 80.97 | 16 | 6 | 7 | 25 | 27 |
Other Current Assets | 8.81 | 11 | 9 | 3 | 1 | 2 |
Total Current Assets | 1,278 | 1,281 | 2,445 | 2,223 | 2,568 | 1,515 |
Property, Plant & Equipment | 24.89 | 27 | 43 | 52 | 77 | 70 |
Long-Term Investments | - | 5 | 7 | 9 | 11 | 15 |
Other Intangible Assets | 4.6 | 4 | 6 | 8 | 11 | 15 |
Long-Term Deferred Tax Assets | - | - | - | - | 3 | 1 |
Other Long-Term Assets | 5.38 | 1 | 2 | 3 | 2 | 1 |
Total Assets | 1,312 | 1,318 | 2,503 | 2,295 | 2,672 | 1,617 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 264.46 | 9 | 135 | 20 | 32 | 17 |
Current Portion of Long-Term Debt | 22.28 | 22 | 21 | 26 | 24 | 24 |
Current Income Taxes Payable | 2.43 | 87 | 158 | 53 | 98 | 74 |
Other Current Liabilities | 41.98 | 289 | 532 | 738 | 453 | 559 |
Total Current Liabilities | 537.21 | 407 | 846 | 837 | 607 | 674 |
Long-Term Debt | 41.36 | 46 | 69 | 90 | 114 | 199 |
Other Long-Term Liabilities | 0 | 2 | 1 | 1 | 1 | - |
Total Liabilities | 578.57 | 455 | 916 | 928 | 722 | 873 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 844.4 | 844 | 825 | 818 | 788 | 231 |
Additional Paid-In Capital | 828.4 | 828 | 809 | 802 | 772 | 215 |
Retained Earnings | -943.09 | -808 | -47 | -252 | 388 | 298 |
Comprehensive Income & Other | 4.13 | -1 | - | -1 | 2 | - |
Shareholders' Equity | 733.83 | 863 | 1,587 | 1,367 | 1,950 | 744 |
Total Liabilities & Equity | 1,312 | 1,318 | 2,503 | 2,295 | 2,672 | 1,617 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 63.64 | 68 | 90 | 116 | 138 | 223 |
Net Cash (Debt) | 635.62 | 901 | 1,448 | 1,767 | 2,023 | 951 |
Net Cash Growth | -54.20% | -37.78% | -18.05% | -12.65% | 112.72% | 157.72% |
Net Cash Per Share | 24.64 | 34.98 | 55.94 | 69.30 | 79.12 | 42.02 |
Filing Date Shares Outstanding | 25.79 | 25.79 | 25.64 | 25.58 | 25.29 | 22.63 |
Total Common Shares Outstanding | 25.79 | 25.79 | 25.64 | 25.58 | 25.29 | 22.63 |
Working Capital | 740.32 | 874 | 1,599 | 1,386 | 1,961 | 841 |
Book Value Per Share | 28.45 | 33.46 | 61.91 | 53.45 | 77.12 | 32.87 |
Tangible Book Value | 729.23 | 859 | 1,581 | 1,359 | 1,939 | 729 |
Tangible Book Value Per Share | 28.27 | 33.30 | 61.67 | 53.13 | 76.68 | 32.21 |